Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan
· Delayed Price · Currency is TWD
Full Chart
Watchlist
Alerts
Compare
145.50
+6.50 (4.68%)
At close: Sep 7, 2026
Overview
Financials
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Semi-Annual
TTM
TPEX:7871 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
TTM
Mil
Millions
Data
Data Source
TWD
TWD
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Revenue
113.34
50.29
0.8
25.7
Revenue Growth
10946.88%
6162.39%
-96.88%
-
Cost of Revenue
0.2
0.3
0.64
2.21
Gross Profit
113.14
49.98
0.17
23.48
Selling, General & Admin
71.7
58.55
52.35
41.42
Research & Development
261.52
187.99
164.63
103.01
Operating Expenses
333.21
246.53
216.97
144.43
Operating Income
-220.07
-196.55
-216.81
-120.95
Interest Expense
-0.8
-0.97
-1.31
-0.61
Interest & Investment Income
22.29
12.11
7.45
0.53
Earnings From Equity Investments
-
-
-0.31
-
Currency Exchange Gain (Loss)
11.55
4.99
2.41
1.92
Other Non Operating Income (Expenses)
21.66
-920.78
-231.39
391.07
EBT Excluding Unusual Items
-165.37
-1,101
-439.95
271.95
Gain (Loss) on Sale of Investments
43.48
9.67
-
-
Gain (Loss) on Sale of Assets
-
-
0.02
-
Other Unusual Items
-
-
-0.39
-
Pretax Income
-121.89
-1,092
-440.32
271.95
Income Tax Expense
33.94
14.97
-
3.74
Net Income
-155.83
-1,107
-440.32
268.21
Net Income to Common
-155.83
-1,107
-440.32
268.21
Net Income Growth
-
-
-
-
Shares Outstanding (Basic)
133
79
22
22
Shares Outstanding (Diluted)
133
79
22
80
Shares Change
461.57%
256.61%
-72.30%
-
EPS (Basic)
-1.17
-14.02
-19.90
12.27
EPS (Diluted)
-1.17
-14.02
-19.90
3.36
EPS Growth
-
-
-
-
Additional Metrics
TTM
Mil
Millions
Data
Data Source
TWD
TWD
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Free Cash Flow
-155.53
-132.48
-249.67
-105.55
Free Cash Flow Per Share
-1.17
-1.68
-11.28
-1.32
Gross Margin
99.83%
99.40%
20.67%
91.38%
Operating Margin
-194.17%
-390.85%
-26999.63%
-470.70%
Profit Margin
-137.48%
-2200.37%
-54833.75%
1043.79%
Free Cash Flow Margin
-137.23%
-263.44%
-31091.78%
-410.76%
EBITDA
-215.13
-191.61
-213.69
-117.9
D&A For EBITDA
4.94
4.94
3.12
3.05
EBIT
-220.07
-196.55
-216.81
-120.95
Effective Tax Rate
-
-
-
1.38%